Home >> Research Area >> 5,8-Dihydroxypsoralen

5,8-Dihydroxypsoralen

CAS# 14348-23-3

5,8-Dihydroxypsoralen

Catalog No. BCC8104----Order now to get a substantial discount!

Product Name & Size Price Stock
5,8-Dihydroxypsoralen:5mg Please Inquire In Stock
5,8-Dihydroxypsoralen:10mg Please Inquire In Stock
5,8-Dihydroxypsoralen:20mg Please Inquire In Stock
5,8-Dihydroxypsoralen:50mg Please Inquire In Stock

Quality Control of 5,8-Dihydroxypsoralen

Number of papers citing our products

Chemical structure

5,8-Dihydroxypsoralen

3D structure

Chemical Properties of 5,8-Dihydroxypsoralen

Cas No. 14348-23-3 SDF Download SDF
PubChem ID 5376215 Appearance Powder
Formula C11H6O5 M.Wt 218
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name 4,9-dihydroxyfuro[3,2-g]chromen-7-one
SMILES C1=CC(=O)OC2=C1C(=C3C=COC3=C2O)O
Standard InChIKey DZEPISXWRUMGFN-UHFFFAOYSA-N
Standard InChI InChI=1S/C11H6O5/c12-7-2-1-5-8(13)6-3-4-15-10(6)9(14)11(5)16-7/h1-4,13-14H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

5,8-Dihydroxypsoralen Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

5,8-Dihydroxypsoralen Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 5,8-Dihydroxypsoralen

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.5872 mL 22.9358 mL 45.8716 mL 91.7431 mL 114.6789 mL
5 mM 0.9174 mL 4.5872 mL 9.1743 mL 18.3486 mL 22.9358 mL
10 mM 0.4587 mL 2.2936 mL 4.5872 mL 9.1743 mL 11.4679 mL
50 mM 0.0917 mL 0.4587 mL 0.9174 mL 1.8349 mL 2.2936 mL
100 mM 0.0459 mL 0.2294 mL 0.4587 mL 0.9174 mL 1.1468 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
  • Cnidilin

    Catalog No.:BCN2731
    CAS No.:14348-22-2
  • Poriol

    Catalog No.:BCN6816
    CAS No.:14348-16-4
  • (Arg)9 peptide

    Catalog No.:BCC5336
    CAS No.:143413-47-2
  • SAR131675

    Catalog No.:BCC5097
    CAS No.:1433953-83-3
  • Naratriptan

    Catalog No.:BCC5053
    CAS No.:143388-64-1
  • Bryostatin 3

    Catalog No.:BCC5620
    CAS No.:143370-84-7
  • SMIP004

    Catalog No.:BCC1955
    CAS No.:143360-00-3
  • RS 56812 hydrochloride

    Catalog No.:BCC6877
    CAS No.:143339-12-2
  • UNC 2400

    Catalog No.:BCC5625
    CAS No.:1433200-49-7
  • Ac-YVAD-CHO

    Catalog No.:BCC4021
    CAS No.:143313-51-3
  • H-Chg-OH

    Catalog No.:BCC3162
    CAS No.:14328-51-9
  • RA-XI

    Catalog No.:BCN3514
    CAS No.:143277-27-4
New Products
 

References on 5,8-Dihydroxypsoralen

Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.[Pubmed:3944766]

J Pharmacol Exp Ther. 1986 Feb;236(2):364-73.

The pharmacokinetics and metabolism of 8-methoxypsoralen (8-MOP) were measured in the catheterized rat after a single i.v. dose. Blood samples were collected serially and analyzed using a sensitive and specific assay for [14C]-8-MOP. Total body clearance of 8-MOP was 7.3, 3.9, 1.7, 1.0, 0.78 and 0.42 liters/kg/hr at doses of 0.2, 1.0, 2.5, 5.0, 10 and 20 mg/kg, respectively. The decline in total body clearance indicates that elimination of 8-MOP is dose-dependent in the rat. After i.v. administration of 10 mg/kg of 8-MOP, 71 and 26% of the dose was recovered within 72 hr in the urine and feces, respectively. Unchanged 8-MOP accounted for less than 1% of the excreted radioactivity. In tissue distribution studies at 0.5, 2 and 5 hr after i.v. administration, 8-MOP distributed rapidly to all tissues and concentrated in the fat and kidneys. The concentration of 8-MOP in the skin was 0.4 to 0.6 times that in the blood. Eleven metabolites of 8-MOP were detected in the urine. The metabolites identified after enzymatic hydrolysis were 8-hydroxypsoralen; 5-hydroxy-8-methoxypsoralen; 5,8-Dihydroxypsoralen; 5,8-dioxopsoralen; 6-(7-hydroxy-8-methoxycoumaryl)-acetic acid and 8-MOP (formed by ring closure of a coumaric acid metabolite). Thus, these studies indicate that 8-MOP is metabolized in the rat by 1) O-demethylation; 2) hydroxylation at position 5; 3) hydrolysis of the lactone ring and 4) oxidation of the furan ring, a pathway already confirmed in insects, dogs and humans.

Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry.[Pubmed:2886306]

Drug Metab Dispos. 1987 May-Jun;15(3):318-28.

The pharmacokinetics and metabolism of 8-methoxypsoralen (8-MOP) were measured in the catheterized rat after pretreatment for 3 days with phenobarbital (PB), beta-naphthoflavone (BNF), 8-MOP, or vehicle. After an iv injection of 10 mg/kg of [14C]8-MOP, timed blood samples were collected and analyzed using a sensitive and specific assay for [14C]8-MOP. Total body clearance of 8-MOP increased from 0.55 +/- 0.06 liter/kg/hr in control rats to 5.6 +/- 0.4, 2.7 +/- 0.4, and 1.2 +/- 0.0 liters/kg/hr in rats pretreated with BNF, PB, and 8-MOP, respectively, indicating that all three compounds are inducers of 8-MOP metabolism. The pattern of urinary metabolites was altered by the enzyme inducers. The urinary excretion of the sulfate conjugate of 5-hydroxy-8-methoxypsoralen was increased from 10 to 40% of the dose after pretreatment with PB. This intact conjugate was identified using thermospray and fast atom bombardment mass spectrometry. Pretreatment with 8-MOP and BNF increased 2- and 3-fold, respectively, the urinary excretion of a labile sulfate conjugate of 5,8-Dihydroxypsoralen. Metabolism of 8-MOP was demonstrated in the 9000 g supernatant and microsomes of rat liver and shown to be inducible by pretreatment of rats with BNF, PB, and 8-MOP. 8-MOP was metabolized in incubations with liver microsomes at rates of 0.22 +/- 0.06, 0.38 +/- 0.06, 0.78 +/- 0.07, and 0.91 +/- 0.03 nmol/min/mg of protein for vehicle, 8-MOP-, PB-, and BNF-pretreated rats, respectively. Results of our investigation indicate that the success of therapy with 8-MOP may be influenced by pharmacokinetic interactions with other drugs.

Fate of [(14)C]xanthotoxin (8-methoxypsoralen) in laying hens and a lactating goat.[Pubmed:24254913]

J Chem Ecol. 1992 Feb;18(2):253-70.

The metabolism of xanthotoxin, a naturally occurring furanocoumarin photosensitizer, was studied in laying hens and a lactating goat treated with single oral doses equivalent to 10 mg xanthotoxin/kg of body weight. Within 48 h, essentially all of the administered radiocarbon was eliminated in the excreta of the laying hens, while in the goat 92% and 3% were excreted in the urine and feces, respectively. Radiocarbon residues in the milk, egg white, and egg yolk were low. Xanthotoxin, 8-hydroxypsoralen (xanthotoxol), 6-(7-hydroxy-8-methoxycoumaryl)-acetic acid (HCA) and 6-(7-hydroxy-8-methoxycoumaryl)-hydroxyacetic acid (HCHA) were identified in the excreta of laying hens. In the goat, xanthotoxin was metabolized to HCA, HCHA, xanthotoxol, 5,8-Dihydroxypsoralen, psoralenquinone, 5-hydroxy-8-methoxy-psoralen and 3[5-(6-hydroxy-7-methoxybenzofuryl)]-propanoic acid. Thus, identified metabolites in one or both of these species arose throughO-demethylation, oxidative cleavage of the furan ring, hydroxylation, reduction, oxidation, and hydrolysis of the lactone ring.

Keywords:

5,8-Dihydroxypsoralen,14348-23-3,Natural Products, buy 5,8-Dihydroxypsoralen , 5,8-Dihydroxypsoralen supplier , purchase 5,8-Dihydroxypsoralen , 5,8-Dihydroxypsoralen cost , 5,8-Dihydroxypsoralen manufacturer , order 5,8-Dihydroxypsoralen , high purity 5,8-Dihydroxypsoralen

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: